France In-Vitro Toxicology Testing Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- In-vitro Toxicology Testing Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI anything about the in-vitro toxicology testing market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
France in-vitro toxicology testing market highlights
- The France in-vitro toxicology testing market generated a revenue of USD 1,407.1 million in 2023 and is expected to reach USD 2,849.9 million by 2030.
- The France market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
In-vitro toxicology testing market data book summary
| Market revenue in 2023 | USD 1,407.1 million |
| Market revenue in 2030 | USD 2,849.9 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, France accounted for 4.5% of the global in-vitro toxicology testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany in-vitro toxicology testing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 3,892.8 million by 2030.
Rising R&D spending by pharmaceutical companies, technological advancements, growing demand for toxicology testing procedures, and supportive regulatory legislation to promote in vitro research studies are among the major factors driving the country’s market.
France in vitro toxicology testing market is competitive owing to the presence of well-established players and significant investment by them. Some of the key players in the country’s market are Bioalternatives, XenTech SAS, and SGS SA. These players specialize in the development of preclinical models for oncology research.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-Vitro Toxicology Testing Market Scope
In-Vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
France In-vitro Toxicology Testing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In-vitro Toxicology Testing Market Outlook will help companies and investors design strategic landscapes.
Pharmaceutical Industry was the largest segment with a revenue share of 42.41% in 2023.
Horizon Databook has segmented the France in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Rising R&D spending by pharmaceutical companies, technological advancements, growing demand for toxicology testing procedures, and supportive regulatory legislation to promote in vitro research studies are among the major factors driving the country’s market.
France in vitro toxicology testing market is competitive owing to the presence of well-established players and significant investment by them. Some of the key players in the country’s market are Bioalternatives, XenTech SAS, and SGS SA. These players specialize in the development of preclinical models for oncology research.
- France In-Vitro Toxicology Testing Market End User Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical Industry
- Cosmetics And Household Products
- Academic Institutes and Research Laboratories
- Diagnostics
- Chemicals Industry
- Food Industry
- France In-Vitro Toxicology Testing Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Cell Culture Tech
- High Throughput Tech
- Molecular Imaging
- OMICS Tech
- France In-Vitro Toxicology Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
- Consumables
- Assays
- Instruments
- Software
- Services
- France In-Vitro Toxicology Testing Market Application Outlook (Revenue, USD Million , 2018-2030)
- Systemic Toxicology
- Dermal Toxicity
- Endorine Disruption
- Occular Toxicity
- Others
- France In-Vitro Toxicology Testing Market Method Outlook (Revenue, USD Million , 2018-2030)
- Cellular Assay
- Biochemical Assay
- In Silica
- Ex-vivo
Reasons to subscribe to In-vitro Toxicology Testing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In-vitro Toxicology Testing Market Outlook databook
- Our clientele includes a mix of In-vitro Toxicology Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France In-vitro Toxicology Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France In-vitro Toxicology Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
France In-Vitro Toxicology Testing Market, 2018-2030 (US$M)
France in-vitro toxicology testing market statistics, by end user, 2018-2030 (US$M)
